Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

计划入组 226 人 · 首次发布于 2008 年 2 月 4 日

A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)

计划入组 43 人 · 首次发布于 2025 年 2 月 19 日

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

计划入组 18 人 · 首次发布于 2023 年 7 月 7 日

renal cell carcinoma program

3B-302

68Ga-NYM096

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

Casdatifan Shows Promise in Metastatic Clear Cell Renal Cell Carcinoma

Belzutifan Plus Cabozantinib Shows Promise as First-Line Treatment for Advanced Clear Cell Renal Cell Carcinoma

TLX250-Px Shows Promise for Diagnosing Multiple Kidney Cancer Types Beyond Clear Cell Renal Cell Carcinoma